KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Inventory Average: 2021-2024

Historic Inventory Average for Esperion Therapeutics (ESPR) over the last 4 years, with Dec 2024 value amounting to $80.1 million.

  • Esperion Therapeutics' Inventory Average rose 35.51% to $111.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.5 million, marking a year-over-year increase of 35.51%. This contributed to the annual value of $80.1 million for FY2024, which is 58.81% up from last year.
  • Latest data reveals that Esperion Therapeutics reported Inventory Average of $80.1 million as of FY2024, which was up 58.81% from $50.4 million recorded in FY2023.
  • Esperion Therapeutics' 5-year Inventory Average high stood at $80.1 million for FY2024, and its period low was $25.3 million during FY2021.
  • Moreover, its 3-year median value for Inventory Average was $50.4 million (2023), whereas its average is $55.1 million.
  • Data for Esperion Therapeutics' Inventory Average shows a peak YoY skyrocketed of 58.81% (in 2024) over the last 5 years.
  • Esperion Therapeutics' Inventory Average (Yearly) stood at $25.3 million in 2021, then surged by 37.73% to $34.8 million in 2022, then skyrocketed by 44.87% to $50.4 million in 2023, then surged by 58.81% to $80.1 million in 2024.